CLL Updates from ASH 2023

Cleveland Clinic Taussig Cancer Institute
A

Frontline CLL Learnings From Phase 3 RESONATE-2, iLLUMINATE, and E1912 Trials

By Cleveland Clinic Taussig Cancer Institute FEATURING Allison Winter
By Cleveland Clinic Taussig Cancer Institute FEATURING Allison Winter
2,370 views
July 14, 2023
Comments 0
Login to view comments. Click here to Login
16:42

SOHO Italy 2023: How to Improve the Use Novel Agents in Elderly Pati…

5th SOHO Italy Annual Conference

A. Ibrahim

75 views
08:18

ASH 2023 Insights: "Effect of Ibrutinib Flexible Dosing Strategies o…

Insights from 2023 ASH Annual Meeting

N. Ghosh

101 views
07:04

Impact of Ibrutinib Dose Reduction on Duration of Therapy in Patient…

Insights from 2023 ASH Annual Meeting

M. Shadman

408 views
06:56

Efficacy of Ibrutinib Arms Across ALPINE and ELEVATE-RR Trials in R/…

Insights from 2023 ASH Annual Meeting

M. Shadman

824 views
18:01

ASH 2023 Insights: "MRD-Directed Therapy in CLL - Ready for Primetim…

Insights from 2023 ASH Annual Meeting

J. Rhodes

329 views